Are you experiencing unbearable pain that hinders your daily activities? If yes, then you might have heard of the medication called Percodan. This prescription drug is a combination of aspirin and oxycodone, providing relief to severe pain caused by various conditions. However, before taking this medication or prescribing it to your patients, it's essential to know how this drug works and its potential side effects. In this blog post, we'll dive deep into everything you need to know about Percodan - from how it works to its possible side effects - so keep reading!
Percodan is a medication used to relieve moderate to severe pain. It contains two active ingredients: oxycodone and aspirin. Oxycodone is an opioid agonist whereas aspirin belongs to the class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs).
Oxycodone works by binding with specific receptors in the central nervous system, including those located in the brain and spinal cord, resulting in reduced sensation of pain. Aspirin, on the other hand, works by inhibiting certain enzymes that cause inflammation and pain.
Together, these two drugs work synergistically to provide effective relief from various types of painful conditions such as dental procedures, surgery, injuries or chronic conditions like arthritis.
However, it's worth noting that Percodan can be habit-forming if taken for long periods or at higher than prescribed doses due to its opioid component. Therefore it should only be taken under medical supervision and never abused or shared with others.
What are the side effects of Percodan?
Percodan is a painkiller medication that contains two active ingredients: oxycodone and aspirin. While it can effectively manage pain, users should be aware of its potential side effects.
One common side effect of Percodan is constipation. This occurs because the medication slows down the digestive system, making bowel movements less frequent and more difficult.
In addition to constipation, drowsiness and dizziness are also common side effects of Percodan. These can impair one's ability to drive or operate heavy machinery, so users should avoid these activities until they know how their body reacts to the medication.
While Percodan can provide relief for moderate-to-severe pain symptoms in the short term; all potential risks must be weighed against its benefits before deciding whether or not it is appropriate for each individual patient’s medical condition.
Percodan is a painkiller medication that can help relieve moderate to severe pain. It contains two main ingredients - oxycodone and aspirin - which work together to provide effective relief. However, like all medications, it comes with potential side effects that should not be ignored.
1.
Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk
2.
Year in Review: Multiple Myeloma
3.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
4.
Beyond What Is Visible in Myelofibrosis?
5.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
1.
Best Clinical Practices in Hematology
2.
The Growing Challenge of Haematological Malignancies in Older Adults
3.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
4.
Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends
5.
Geriatric Oncology and Treatment Sequencing: Evidence-Based Approaches for the Aging Cancer Population
1.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Symposium on Oncology, Cardiology and Critical Care Innovations
4.
International Conference on Cancer Nursing and Hematology Support
5.
International Conference on Clinical Medicine and Surgical Care
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation